Name
XGEVA - (US)
Ingredients/Formulations
[DENOSUMAB]
Composition
INJ - 120 MG/1.7 ML (70 MG/ML) SINGLE-USE VIAL.
Dosage Form
INJ
Dosage Remarks
BONE METASTASIS FROM SOLID TUMORS : 120 MG AS S/C INJ EVERY 4 WKS IN THE UPPER ARM, UPPER THIGH, OR ABDOMEN. GIANT CELL TUMOR OF BONE: 120 MG S/C EVERY 4 WKS WITH ADDITIONAL 120 MG DOSES ON DAYS 8 AND 15 OF THE FIRST MONTH OF THERAPY.
Manufacturer Name
AMGEN-BP
Group Name
[ANTICANCER] , [MONOCLONAL ANTIBODY]
Alternate Brands
Brand Interaction
Brand Safety